Vermont Tech Scene
SEE OTHER BRANDS

Exploring the science and technology news of Vermont

Vermont Tech Scene: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.

Press releases published on June 5, 2025

Castellum, Inc. Retires Promissory Note Early

Castellum, Inc. Retires Promissory Note Early

VIENNA, Va., June 05, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) (“Castellum” or “CTM”), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces that it has retired its …

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

PORTLAND, Maine, June 05, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

Jill Martin Joins MOBIA as Director of Sales

Jill Martin Joins MOBIA as Director of Sales

DARTMOUTH, Nova Scotia, June 05, 2025 (GLOBE NEWSWIRE) -- MOBIA, Canada’s leading business transformation partner, is thrilled to welcome Jill Martin to its team, marking a new chapter in the company’s strategy to grow its presence across Canada. A dynamic …

Iran-aligned BladedFeline spies on Iraqi and Kurdish officials, ESET Research discovers

Iran-aligned BladedFeline spies on Iraqi and Kurdish officials, ESET Research discovers

ESET researchers have revealed that Iran-aligned threat group BladedFeline targeted Kurdish and Iraqi government officials with array of malicious tools discovered within their systems. ESET discovered and analyzed two reverse tunnels (Laret and Pinar), a …

LyondellBasell tritt in eine Vereinbarung und exklusive Verhandlungen mit AEQUITA über den Verkauf von vier europäischen Vermögenswerten im Rahmen der strategischen Bewertung ein

LyondellBasell tritt in eine Vereinbarung und exklusive Verhandlungen mit AEQUITA über den Verkauf von vier europäischen Vermögenswerten im Rahmen der strategischen Bewertung ein

ROTTERDAM, Niederlande, June 05, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (LYB) gab heute bekannt, dass das Unternehmen eine Vereinbarung eingegangen ist und exklusive Verhandlungen mit AEQUITA über den Verkauf ausgewählter Vermögenswerte aus dem Olefine- …

LyondellBasell llega a un acuerdo y negociaciones exclusivas con AEQUITA para la venta de los cuatro activos incluidos en la evaluación estratégica europea 

LyondellBasell llega a un acuerdo y negociaciones exclusivas con AEQUITA para la venta de los cuatro activos incluidos en la evaluación estratégica europea 

ROTTERDAM, Países Bajos, June 05, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (LYB) anunció hoy que ha llegado a un acuerdo y negociaciones exclusivas con AEQUITA para la venta de una selección de activos de olefinas y poliolefinas y el negocio asociado en …

LyondellBasell enters into an agreement and exclusive negotiations with AEQUITA for the sale of four European Strategic Assessment assets

LyondellBasell enters into an agreement and exclusive negotiations with AEQUITA for the sale of four European Strategic Assessment assets

ROTTERDAM, The Netherlands, June 05, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (LYB) today announced that it has entered into an agreement and exclusive negotiations with AEQUITA for the sale of select olefins …

LyondellBasell conclut un accord et entame des négociations exclusives avec AEQUITA pour la vente de quatre actifs issus de son évaluation stratégique européenne 

LyondellBasell conclut un accord et entame des négociations exclusives avec AEQUITA pour la vente de quatre actifs issus de son évaluation stratégique européenne 

ROTTERDAM, Pays-Bas, 05 juin 2025 (GLOBE NEWSWIRE) -- LyondellBasell (LYB) a annoncé aujourd’hui avoir conclu un accord et entamé des négociations exclusives avec AEQUITA pour la vente de certains actifs oléfines et polyoléfines et les activités associées …

Osivax Announces Last Patient Last Visit  in Phase 2a Trial Evaluating a Booster Dose of Broad-Spectrum Influenza Vaccine OVX836 s release

Osivax Announces Last Patient Last Visit in Phase 2a Trial Evaluating a Booster Dose of Broad-Spectrum Influenza Vaccine OVX836 s release

Final results expected in H2 2025 Lyon, France – June 5, 2025 – Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating respiratory viruses, today announced that all participants have completed …

Strategic merger: Agelec joins the Videlio group

Strategic merger: Agelec joins the Videlio group

The growing challenges of supervision, decision-making efficiency, and security for institutions and businesses have led Videlio, a major player in audiovisual and IT integration, to take a step forward in the development of a new strategic activity: …

Rapprochement stratégique : Agelec rejoint le groupe Videlio

Rapprochement stratégique : Agelec rejoint le groupe Videlio

Les enjeux croissants de supervision, d’efficacité décisionnelle et de sécurité des institutions et des entreprises ont amené Videlio, acteur majeur dans l’intégration audiovisuelle et IT, à franchir un cap dans le développement d’une nouvelle activité …

Oculis Publishes Results of 2025 Annual General Meeting

Oculis Publishes Results of 2025 Annual General Meeting

ZUG, Switzerland, June 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), today announced the results from its 2025 Annual General Meeting held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, …

Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan

Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan

Sanofi Launches 2025 Global Employee Stock Purchase Plan Paris, June 5, 2025. Sanofi’s global employee shareholder plan, Action 2025, opens on June 10, 2025, to around 70,000 employees in 55 countries. Now in its 11th year, the program demonstrates the …

Communiqué de presse : Sanofi lance son plan mondial 2025 d’actionnariat salarié

Communiqué de presse : Sanofi lance son plan mondial 2025 d’actionnariat salarié

Sanofi lance son plan mondial 2025 d’actionnariat salarié Paris, le 5 juin 2025. Sanofi lance Action 2025, son plan mondial d’actionnariat salarié, qui sera ouvert le 10 juin 2025 à environ 70 000 salariés dans 55 pays. Ce plan, qui entre dans sa onzième …

SPEC Resumes Global Collaboration with Companies on U.S. BIS Entity List

SPEC Resumes Global Collaboration with Companies on U.S. BIS Entity List

GAINESVILLE, Va., June 05, 2025 (GLOBE NEWSWIRE) -- Standard Performance Evaluation Corp. (SPEC), the trusted leader in computing benchmarks, announced today that SPEC International Standards Group (ISG) successfully advocated that the United States …

Atos fournira les services et applications informatiques clés pour l'UEFA Nations League Finals™ 2025

Atos fournira les services et applications informatiques clés pour l'UEFA Nations League Finals™ 2025

                                                                Communiqué de presse Atos fournira les services et applications informatiques clés pour l'UEFA Nations League Finals™ 2025 Paris, France – le 5 juin 2025 – Atos, partenaire informatique …

Atos to deliver key IT services and applications for UEFA Nations League Finals™ 2025

Atos to deliver key IT services and applications for UEFA Nations League Finals™ 2025

                                                                Press Release Atos to deliver key IT services and applications for UEFA Nations League Finals™ 2025 Paris, France – 5 June, 2025 – Atos, the Official Information Technology Partner of UEFA …

CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle

CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle

Lehi, June 05, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 5, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform designed to use the body’s immune system to treat cancer, today announced the successful creation …

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)

HYDERABAD, India and REYKJAVIK, Iceland, June 05, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Reddy’s …

Juvenescence acquires AI drug discovery company Ro5 to boost R&D capabilities and drive pipeline of medicines to extend healthy lifespan

Juvenescence acquires AI drug discovery company Ro5 to boost R&D capabilities and drive pipeline of medicines to extend healthy lifespan

Ro5 Inc. acquisition enhances artificial intelligence/machine learning drug discovery capabilities Strategic addition strengthens Juvenescence’s AI-enabled therapeutics pipeline and supports partnership with M42 (Mubadala) Acquisition follows $76m Series B …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service